PF-03550096

PF-03550096 is an orally active synthetic cannabinoid (CB) that selectively targets peripheral CB2 receptors with a Ki value of 7.9 nM. PF-03550096 has analgesic activity[1].

Product Specifications

CAS Number

[910376-39-5]

UNSPSC

12352005

Target

Cannabinoid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/pf-03550096.html

Solubility

10 mM in DMSO

Smiles

O=C(N1C2=CC=CC=C2N(CCC(C)(O)C)C1=O)N[C@H](C(N)=O)C(C)(C)C

Molecular Formula

C19H28N4O4

Molecular Weight

376.45

References & Citations

[1]Kikuchi A, et al. Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity. J Pharmacol Sci. 2008 Feb;106 (2) :219-24.